MedTrace Logo

Measuring Geographic Atrophy in AMD Patients Using the Nidek MP-3 Microperimetry Device

NCT02445313 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-02-15

No results posted yet for this study

Summary

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whether these changes are useful in the diagnosis and treatment of eye diseases. Using images of previous participants will allow us to demonstrate the advancement of different technologies, as well be used to allow comparisons between current technologies.

Conditions

  • Age-related Macular Degeneration (AMD)

Interventions

DEVICE

Nidek MP-3

Nidek MP-3 device to be used to take images which will allow measurement of GA in patients with AMD

Sponsors & Collaborators

  • Doheny Image Reading Center

    lead OTHER

Principal Investigators

  • Srinivas Sadda · Doheny Eye Institute

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2019-02-12
Completion
2019-02-12

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02445313 on ClinicalTrials.gov